

Cover Story
By Matthew Bin Han Ong
Utilization data compiled by Flatiron Health and made available to The Cancer Letter make it possible to visualize the dramatic uptake of immunotherapy drugs in the academic and community settings.
In Brief
Drugs & Targets
Trending Stories
- Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts - John Burklow replaced by Seana Cranston as NIH chief of staff
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - NCI summarizes changes to the CCSG NOFO
- AACR announces 2025 Scientific Achievement Award recipients
- The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty
“We are resolute. We are committed to continuing to move the work forward.”